CLINICAL_TRIALS
trial_result
· 2017-02-02
Clinical Trial Update: Lurasidone and Cognition in Bipolar I Disorder [Phase 3]
Summary
A Phase 3 study evaluating lurasidone for cognitive outcomes in Bipolar I Disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of British Columbia | Conditions: Bipolar I Disorder | Phase 3 | Status: COMPLETED